Statistically significant means there is a very high likelihood the drug impacted its target. But if data are not clinically ...

The energy component—and cost—associated with artificial intelligence should not be overlooked in all the excitement.

The importance of a strategic approach and proper due diligence in unlocking the full potential of these arrangements.

Approval makes Gomekli the first treatment to be approved for both adults and pediatric patients for neurofibromatosis type 1 ...

Monica Martin de Bustamante, senior partner and head of advisory at Trinity Life Sciences, spoke with Pharmaceutical ...

New cases are still being recorded, and the impact of long COVID has yet to be fully determined. Invivyd announced a ...

In this Pharmaceutical Executive video interview, Ian Baer, Founder & CEO of Sooth, speaks about how distrust and uncertainty ...

Funding was led by New Enterprise Associates, with participation from Foresite Capital and multiple other investors.

In this Pharmaceutical Executive video interview, Edoardo Madussi, Head of Business Development, Intelligencia AI explains how the environmental impact of LLMs fit into the larger sustainability ...

Join us as Mohit Manrao, SVP and head of US oncology at AstraZeneca, shares his patient-centered approach to transforming cancer care, bridging the gap between innovative science and tangible patient ...

CEO Richard Francis reflects on Teva’s return to growth during his tenure, and what’s next for the drugmaker in its quest to ...

Emblaveo marks the first and only fixed-dose intravenous monobactam/β-lactamase inhibitor combination antibiotic to be ...